ArticleOncogene2026
Strand-asymmetric G-runs and G4s downstream of TSS modulate tumor suppressor gene transcription.
Article in Oncogene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A genome sequence is not made up of random nucleotides. Instead, it has distinctive features for evolutionary adaptation. Herein, we identified a higher frequency of continuous guanines (G-runs) located downstream of the transcription start site (TSS) in the non-template strand than that of the template strand by analyzing the genomic region around TSS (TSS ± 1 kb) across different species. G-runs are known to have the propensity to form G-quadruplex structures (G4). By integrative analysis of large-scale multi-omic datasets, predicted G4 structures in TSS downstream region (TSS-to-+300 bp) of the non-template strand were found to be associated with lower promoter DNA methylation, more accessible chromatin, and higher transcript levels. Compared to non-cancer genes, tumor-suppressor genes (TSGs) exhibited a higher G-run frequency in TSS downstream region (TSS-to-+300 bp) of the non-template strand, contributing to both their high transcript levels and resistance to tumor-specific downregulation. These results were successfully validated with independent datasets. Taken together, our study reveals an evolutionarily conserved higher G-run frequency in TSS downstream region (TSS-to-+300 bp) of the non-template strand as a beneficial genetic feature of TSGs for optimizing their function in tumor suppression.
Indexed as
Identifiers
41927793What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.